Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chromium (51Cr) edetate
- Development stage
- Unknown
- Lead developer
- Marnel Pharmaceuticals
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Chromium Cr-51 EDTA is a small-molecule radiopharmaceutical diagnostic agent used primarily for the estimation of glomerular filtration rate (GFR). It consists of the radioactive isotope chromium-51 complexed with the chelating agent ethylenediamine tetraacetic acid (EDTA). Following intravenous administration, the complex is almost exclusively cleared from the plasma by glomerular filtration, with negligible tubular secretion or reabsorption and minimal binding to plasma proteins. These pharmacokinetic properties make it an ideal marker for the precise assessment of renal function. It is also utilized in research settings for intestinal permeability studies and plasma clearance investigations.
- Brand names
- BACMIN
- Other names
- Chromium Cr-51 EDTAChromium Cr-51 EdetateCr-51-ethylenediamine tetraacetic acidCr51-ethylenediamine tetraacetic acidCr 51-ethylenediamine tetraacetic acidChromium-51-EDTAChromium51-EDTAChromium 51-EDTA
Beyond the preview
Go deeper on chromium (51Cr) edetate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chromium (51Cr) edetate.